The heme oxygenases oxidize heme to biliverdin, carbon monoxide, and ferrous iron. Although this process was once considered simply a mechanism for the catabolic elimination of excess heme, work over the past decade has firmly established that the mammalian heme oxygenases and their three products also have important roles in antiinflammatory and signaling pathways. The recent medical literature indicates that CO and biliverdin are involved in the prevention of allograft rejection, inflammation, cardiovascular disorders, and a variety of other medical pathologies. Over the past four years, we have determined the crystal structure of human heme oxygenase and made considerable progess in characterizing the protein, elucidating its mechanism, and defining its interactions with ancillary reductase proteins and agents such as NO. We propose in the continuation of this project to (a) define the structure of the enzyme throughout its catalytic stages by x-ray crystallography, NMR, and other spectroscopic methods; (b) further clarify at the molecular level the mechanism of the enzyme as it sequentially converts heme to alpha-meso-hydroxyheme, verdoheme, iron-biliverdin, and finally to the free products biliverdin and iron; (c) to isolate and characterize the heme oxygenase from Candida albicans, a potential target for anti-fungal agents, and explore its relationship with the heme binding protein obtained from Saccharomyces cerevisiae that only has heme oxygenase activity in the presence of yeast membranes, (d) to further investigate the protein-protein interactions associated with the heme oxygenase system, and (e) to design and construct probes of the heine oxygenase mechanism and agents that can specifically inhibit the activity of the mammalian and fungal enzymes. The work proposed here will yield a detailed characterization of the human heme oxygenase that can be used to clarify the biology of the enzyme and to design small molecule inhibitors and stimulators with practical applications in heme oxygenase-related medical phenomena. The results wilt also contribute to our ongoing development of a general paradigm for catalytic hemoprotein function, as heme oxygenase catalyzes a highly unusual series of steps that diverge completely from the normal pathway followed by other hemoprotein catalysts.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK030297-23
Application #
6819045
Study Section
Physical Biochemistry Study Section (PB)
Program Officer
Badman, David G
Project Start
1982-01-01
Project End
2009-06-30
Budget Start
2004-09-01
Budget End
2005-06-30
Support Year
23
Fiscal Year
2004
Total Cost
$272,718
Indirect Cost
Name
University of California San Francisco
Department
Pharmacology
Type
Schools of Pharmacy
DUNS #
094878337
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Peng, Dungeng; Ogura, Hiroshi; Ma, Li-Hua et al. (2013) Solution NMR characterization of magnetic/electronic properties of azide and cyanide-inhibited substrate complexes of human heme oxygenase: implications for steric ligand tilt. J Inorg Biochem 121:179-86
Meitzler, Jennifer L; Hinde, Sara; Bánfi, Botond et al. (2013) Conserved cysteine residues provide a protein-protein interaction surface in dual oxidase (DUOX) proteins. J Biol Chem 288:7147-57
Varfaj, Fatbardha; Lampe, Jed N; Ortiz de Montellano, Paul R (2012) Role of cysteine residues in heme binding to human heme oxygenase-2 elucidated by two-dimensional NMR spectroscopy. J Biol Chem 287:35181-91
Nishida, Clinton R; Ortiz de Montellano, Paul R (2011) Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases. Chem Biol Interact 192:21-5
Meitzler, Jennifer L; Ortiz de Montellano, Paul R (2011) Structural stability and heme binding potential of the truncated human dual oxidase 2 (DUOX2) peroxidase domain. Arch Biochem Biophys 512:197-203
Evans, John P; Kandel, Sylvie; Ortiz de Montellano, Paul R (2009) Isocyanides inhibit human heme oxygenases at the verdoheme stage. Biochemistry 48:8920-8
Ogura, Hiroshi; Evans, John P; Peng, Dungeng et al. (2009) The orbital ground state of the azide-substrate complex of human heme oxygenase is an indicator of distal H-bonding: implications for the enzyme mechanism. Biochemistry 48:3127-37
Meitzler, Jennifer L; Ortiz de Montellano, Paul R (2009) Caenorhabditis elegans and human dual oxidase 1 (DUOX1) ""peroxidase"" domains: insights into heme binding and catalytic activity. J Biol Chem 284:18634-43
Jiang, Yongying; Trnka, Michael J; Medzihradszky, Katalin F et al. (2009) Covalent heme attachment to the protein in human heme oxygenase-1 with selenocysteine replacing the His25 proximal iron ligand. J Inorg Biochem 103:316-25
Peng, Dungeng; Ogura, Hiroshi; Zhu, Wenfeng et al. (2009) Coupling of the distal hydrogen bond network to the exogenous ligand in substrate-bound, resting state human heme oxygenase. Biochemistry 48:11231-42

Showing the most recent 10 out of 66 publications